23 related articles for article (PubMed ID: 14530877)
1. Relationship between inflammatory cytokines and cardiorenal anemia syndrome: treatment with recombinant human erythropoietin (rhepo).
Perunicic-Pekovic G; Pljesa S; Rasic Z; Komadina LJ; Markovic R; Lambic LJ; Celeketic D
Hippokratia; 2008 Jul; 12(3):153-6. PubMed ID: 18923748
[TBL] [Abstract][Full Text] [Related]
2. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.
Derebail VK; Lacson EK; Kshirsagar AV; Key NS; Hogan SL; Hakim RM; Mooney A; Jani CM; Johnson C; Hu Y; Falk RJ; Lazarus JM
J Am Soc Nephrol; 2014 Apr; 25(4):819-26. PubMed ID: 24459231
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with β-thalassaemia.
Mancini R; Marinelli L; Mirante N; Gallo A; Matteocci A; Terlizzi F; Palange M; Fioravanti D; Donnini L; Pierelli L
Blood Transfus; 2012 Jan; 10(1):39-44. PubMed ID: 22153690
[TBL] [Abstract][Full Text] [Related]
4. Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.
Derebail VK; Nachman PH; Key NS; Ansede H; Falk RJ; Rosamond WD; Kshirsagar AV
Kidney Int; 2011 Nov; 80(9):992-999. PubMed ID: 21849972
[TBL] [Abstract][Full Text] [Related]
5. Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity.
Barcellini W; Revelli N; Imperiali FG; Villa MA; Manera MC; Paccapelo C; Zaninoni A; Zanella A
Int J Hematol; 2010 Jun; 91(5):762-9. PubMed ID: 20454945
[TBL] [Abstract][Full Text] [Related]
6. Current state and perspectives on erythropoietin production.
Lee JS; Ha TK; Lee SJ; Lee GM
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1405-16. PubMed ID: 22820523
[TBL] [Abstract][Full Text] [Related]
7. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
[TBL] [Abstract][Full Text] [Related]
8. Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes.
Voulgari PV; Hatzimichael EC; Tsiara S; Tzallas C; Drosos AA; Bourantas KL
Eur J Haematol; 2001 Jan; 66(1):31-6. PubMed ID: 11168505
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of preoperative erythropoietin administration in pediatric neuromuscular scoliosis patients.
Vitale MG; Privitera DM; Matsumoto H; Gomez JA; Waters LM; Hyman JE; Roye DP
Spine (Phila Pa 1976); 2007 Nov; 32(24):2662-7. PubMed ID: 18007241
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
12. Antierythropoietin antibodies in thalassemia patients.
Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
[TBL] [Abstract][Full Text] [Related]
13. [Guidelines for the treatment of anemia in chronic renal failure].
Triolo G;
G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
